1.1 	A bill for an act
1.2 	relating to health; modifying fees for patient enrollment in the medical cannabis 
1.3 	program;amending Minnesota Statutes 2020, section 152.35.
1.4 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.5 	Section 1. Minnesota Statutes 2020, section 152.35, is amended to read:
1.6 	152.35 FEES; DEPOSIT OF REVENUE.
1.7 	(a) The commissioner shall collect an enrollment fee of $200 $40 from patients enrolled 
1.8 	under this section 152.27. If the patient provides evidence of receiving Social Security 
1.9 	disability insurance (SSDI), Supplemental Security Income (SSI), veterans disability, or 
1.10 	railroad disability payments, or being enrolled in medical assistance or MinnesotaCare, then 
1.11 	the fee shall be $50. For purposes of this section:
1.12 	(1) a patient is considered to receive SSDI if the patient was receiving SSDI at the time 
1.13 	the patient was transitioned to retirement benefits by the United States Social Security 
1.14 	Administration; and
1.15 	(2) veterans disability payments include VA dependency and indemnity compensation.
1.16 	Unless a patient provides evidence of receiving payments from or participating in one of 
1.17 	the programs specifically listed in this paragraph, the commissioner of health must collect 
1.18 	the $200 enrollment fee from a patient to enroll the patient in the registry program. The fees 
1.19 	shall be payable annually and are due on the anniversary date of the patient's enrollment. 
1.20 	The fee amount shall be deposited in the state treasury and credited to the state government 
1.21 	special revenue fund.
2.1 	(b) The commissioner shall collect an application fee of $20,000 from each entity 
2.2 	submitting an application for registration as a medical cannabis manufacturer. Revenue 
2.3 	from the fee shall be deposited in the state treasury and credited to the state government 
2.4 	special revenue fund.
2.5 	(c) The commissioner shall establish and collect an annual fee from a medical cannabis 
2.6 	manufacturer equal to the cost of regulating and inspecting the manufacturer in that year. 
2.7 	Revenue from the fee amount shall be deposited in the state treasury and credited to the 
2.8 	state government special revenue fund.
2.9 	(d) A medical cannabis manufacturer may charge patients enrolled in the registry program 
2.10 	a reasonable fee for costs associated with the operations of the manufacturer. The 
2.11 	manufacturer may establish a sliding scale of patient fees based upon a patient's household 
2.12 	income and may accept private donations to reduce patient fees.

2.13 	EFFECTIVE DATE. This section is effective July 1, 2022.